Expression of the TIMP2 gene is not regulated by promoter hypermethylation in the Caski cell line

Guerry SL, De Rosa CJ, Markowitz LE, et al: Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine. 29:2235–2241. 2011. View Article : Google Scholar : PubMed/NCBI

I-Wen T, Pei-Chi H, Kuan-Der L, et al: Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res. 71:4653–4663. 2011. View Article : Google Scholar : PubMed/NCBI

Esteller M, Corn PG, Baylin SB, et al: A gene hypermethylation profile of human cancer. Cancer Res. 61:3225–3229. 2001.PubMed/NCBI

Mohanam S, Wang SW, Rayford A, et al: Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin Exp Metastasis. 13:57–62. 1995. View Article : Google Scholar : PubMed/NCBI

Hajitou A, Sounni NE, Devy L, et al: Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Cancer Res. 61:3450–3457. 2001.PubMed/NCBI

DeClerck YA, Perez N, Shimada H, et al: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52:701–708. 1992.PubMed/NCBI

Valente P, Fassina G, Melchiori A, et al: TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer. 19:246–253. 1998. View Article : Google Scholar : PubMed/NCBI

Suzuki H, Gabrielson E, Chen W, et al: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet. 31:141–149. 2002. View Article : Google Scholar : PubMed/NCBI

Ivanova T, Vinokurova S, Petrenko A, et al: Frequent hypermethylation of 5′ flanking region of TIMP-2 gene in cervical cancer. Int J Cancer. 108:882–886. 2004.

Freshney RI: Culture of Animal Cells A Manual of Basic Techniques. John Wiley & Sons; New York: 1994

Davidson B, Goldberg I, Kpopolovic J, et al: MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma: a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol. 73:372–382. 1999. View Article : Google Scholar : PubMed/NCBI

Nuovo GJ, MacConnell PB, Simsir A, et al: Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 55:267–275. 1995.

Silva Cardeal LB, Brohem CA, Silveira Corrêa TC, et al: Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem Cell Biol. 84:713–719. 2006.PubMed/NCBI

Jianduan L, Zhengyan Z, Miri B, et al: IGSF4 promoter methylation and expression silencing in human cervical cancer. Gynecol Oncol. 96:150–158. 2005. View Article : Google Scholar : PubMed/NCBI